Investors are betting the protein toolbox of the four-year-old startup can solve one of gene therapy’s trickiest problems: getting treatments into the patient’s body.
Category: Editors’ Pick
2022 Breakthrough Prizes Announced: mRNA Vaccine Pioneers Awarded $3 Million
Drew Weissman and Katalin Kariko, whose work was fundamental in developing the Pfizer/BioNTech and Moderna Covid vaccines, were among the winners of the annual awards given to noteworthy scientists.
This Startup Just Raised $50 Million To Deliver Gene Therapies For Rare Diseases
iECURE aims to use gene editing to treat patients suffering from rare genetic disorders.
InnovationRx: Theranos On Trial; Plus, Idaho Rations Hospital Care
InnovationRx is your weekly digest of healthcare news. Sign up!
Wildfire Pollution Kills Thousands Of Americans Each Year, Study Finds
There are nearly 3,200 deaths in the U.S. each year tied to wildfire pollution, the researchers found, one of the highest tolls in the world.
Fewer Americans Than Ever Think Biden Has A Clear Plan To Fight Covid, Poll Finds
The poll reveals Americans’ worst review of Biden’s pandemic messaging in his time as a presidential candidate, president-elect and president.
COP26 Organizers Told: Postpone Conference Or Risk Shutting Out Poorest Nations
A network of leading NGOs and charities has called for the COP26 climate conference to be postponed, saying that vaccine inequality means many developing nations will not be able to attend, which could upend climate progress.
By The Numbers: Who’s Refusing Covid Vaccinations—And Why
Hospitals are filling up with Covid patients with one thing in common: they’re not vaccinated. Here’s who they are.
Here Are The States Searching Most For Unproven Covid ‘Cure’ Ivermectin
There have been massive increases in online searches for ivermectin, an antiparasitic repeatedly determined to be of no benefit in treating or preventing Covid-19, in areas with some of the lowest vaccination rates in the country.
Trustees Report Spells Trouble For Bernie’s Misguided Medicare Expansion
Before Washington considers adding benefits that would further increase costs, it must find a way to pay for the promises it’s already made.
